Shugarts, J.; Amado, A.; Praska, T.; Camou, M.; Niu, J.
Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum. Reports 2025, 8, 96.
https://doi.org/10.3390/reports8020096
AMA Style
Shugarts J, Amado A, Praska T, Camou M, Niu J.
Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum. Reports. 2025; 8(2):96.
https://doi.org/10.3390/reports8020096
Chicago/Turabian Style
Shugarts, Jacquelyn, Aida Amado, Taylor Praska, Monica Camou, and Jiaxin Niu.
2025. "Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum" Reports 8, no. 2: 96.
https://doi.org/10.3390/reports8020096
APA Style
Shugarts, J., Amado, A., Praska, T., Camou, M., & Niu, J.
(2025). Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum. Reports, 8(2), 96.
https://doi.org/10.3390/reports8020096
